‘It’s like Viagra’


GLP-1 Wegovy gets set for PBS listing, as other weight loss drug giants accelerate efforts in the multi-billion dollar market Glucagon-like peptide-1 (GLP-1) Wegovy is slated to be listed on the Pharmaceutical Benefits Scheme (PBS) for patients with heart disease and severe obesity, as drug companies continue their bid for market share with other weight

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Emergency measures as fires continue
Next World News Wrapup: 15 January 2026